In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.

Abstract:

:Aberrant signal transduction has been implicated in malignant transformation, growth, and progression. This has led to the proposal to use inhibitors of signal transduction pathways to treat cancer. One approach to circumventing potential toxicity and improving efficacy would be to target pathways upon which cancer cells selectively depend. Pathways associated with the malignant process involve calcium fluxes, the release of arachidonic acid, and the generation of phosphoinositides. In this report, CAI (L651582, NSC 609974), a substituted carboxyamido-imidazole and novel inhibitor of these selected signal transduction pathways, inhibits anchorage-dependent and -independent growth in a large series of human cancer cell lines. CAI pretreatment of HT-29 human colon cancer and 5R ras-transfected rat embryo fibroblast cells inhibits the formation and growth of experimental pulmonary metastases in nude mice. Oral administration of CAI in PEG-400 vehicle arrests growth and metastasis of transplanted human melanoma and ovarian cancer xenografts. No significant gross or histological toxicity was observed at CAI doses yielding blood levels in the concentration range demonstrated to inhibit select signal transduction pathways in vitro. These data indicate the feasibility and demonstrate a potential selectivity and sensitivity of using specific signal transduction inhibitors for the experimental treatment of cancer.

journal_name

Cancer Res

journal_title

Cancer research

authors

Kohn EC,Sandeen MA,Liotta LA

subject

Has Abstract

pub_date

1992-06-01 00:00:00

pages

3208-12

issue

11

eissn

0008-5472

issn

1538-7445

journal_volume

52

pub_type

杂志文章
  • Prolonged ornithine decarboxylase induction in regenerating carcinogen-treated liver.

    abstract::A cascade of events leading to hypertrophy has been proposed and implicated in growth regulation in a variety of normal and neoplastic cells and tissues. There is a tightly coupled temporal sequence: (a) cyclic adenosine 3':5'-monophosphate-dependent protein kinase (cAPK) activation; (b) ornithine decarboxylase (ODC) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Olson JW,Russell DH

    更新日期:1980-12-01 00:00:00

  • Growth of preneoplastic mammary epithelial cells in serum-free medium.

    abstract::The conditions for growing preneoplastic mammary epithelial cells in primary cell cultures with serum-free factor-defined medium were established in a series of experiments. The cells, grown in Dulbecco's modified Eagle's medium with 0.6 mM Ca2+, epidermal growth factor, transferrin, insulin, and Na2SeO3, were fibrobl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Medina D,Oborn CJ

    更新日期:1980-11-01 00:00:00

  • Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo.

    abstract::The mitochondrial peripheral benzodiazepine receptor (mPBR) is involved in a functional structure designated as the permeability transition pore, which controls apoptosis. Binding of Fas/APO-1/CD95 triggers a prototypic apoptosis-inducing pathway. Using four different human tumor cell lines (T-cell Jurkat, neuroblasto...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Decaudin D,Castedo M,Nemati F,Beurdeley-Thomas A,De Pinieux G,Caron A,Pouillart P,Wijdenes J,Rouillard D,Kroemer G,Poupon MF

    更新日期:2002-03-01 00:00:00

  • Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.

    abstract::Sphingosine-1-phosphate is a potent lipid mediator formed by phosphorylation of sphingosine, a metabolite of sphingolipids, catalyzed by two sphingosine kinase (SphK) isoenzymes, SphK1 and SphK2. Expression of SphK2, which is enriched in the nucleus of MCF7 human breast cancer cells, increased expression of the cyclin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2090

    authors: Sankala HM,Hait NC,Paugh SW,Shida D,Lépine S,Elmore LW,Dent P,Milstien S,Spiegel S

    更新日期:2007-11-01 00:00:00

  • Proteasome function is required for DNA damage response and fanconi anemia pathway activation.

    abstract::Proteasome inhibitors sensitize tumor cells to DNA-damaging agents, including ionizing radiation (IR), and DNA cross-linking agents (melphalan and cisplatin) through unknown mechanisms. The Fanconi anemia pathway is a DNA damage-activated signaling pathway, which regulates cellular resistance to DNA cross-linking agen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1015

    authors: Jacquemont C,Taniguchi T

    更新日期:2007-08-01 00:00:00

  • Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.

    abstract::A phase I clinical trial with granulocyte-macrophage colony-stimulating factor tumor cell vaccines in patients with metastatic renal cell carcinoma (RCC) showed immune cell infiltration at vaccine sites and delayed-type hypersensitivity (DTH) responses to autologous tumor cells indicative of T-cell immunity. To furthe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhou X,Jun DY,Thomas AM,Huang X,Huang LQ,Mautner J,Mo W,Robbins PF,Pardoll DM,Jaffee EM

    更新日期:2005-02-01 00:00:00

  • Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.

    abstract::Monoclonal antibodies (MAbs) targeted to glioma-associated antigens may allow the selective delivery of imaging and therapeutic agents to brain tumors; the use of MAb fragments may be a strategy to further improve tumor uptake of such agents relative to normal tissues. In this study, we have examined the in vivo local...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Colapinto EV,Humphrey PA,Zalutsky MR,Groothuis DR,Friedman HS,de Tribolet N,Carrel S,Bigner DD

    更新日期:1988-10-15 00:00:00

  • MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.

    abstract::Despite the fact that osteosarcoma is one of the most common primary bone malignancies with poor prognosis, the mechanism behind the pathogenesis of osteosarcoma is only partially known. Here we characterized differentially expressed genes by extensive analysis of several publicly available gene expression profile dat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1764

    authors: Chen Y,Wang T,Huang M,Liu Q,Hu C,Wang B,Han D,Chen C,Zhang J,Li Z,Liu C,Lei W,Chang Y,Wu M,Xiang D,Chen Y,Wang R,Huang W,Lei Z,Chu X

    更新日期:2020-06-15 00:00:00

  • Metabolic activation of 6-nitrochrysene in explants of human bronchus and in isolated rat hepatocytes.

    abstract::It has previously been shown that 6-nitrochrysene can be activated to electrophilic species capable of reacting with DNA through metabolic pathways that form N-hydroxy-6-aminochrysene or trans-1,2-dihydroxy-1,2-dihydro-6-aminochrysene as critical intermediates. Since the lung is a known target tissue for the carcinoge...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Delclos KB,el-Bayoumy K,Casciano DA,Walker RP,Kadlubar FF,Hecht SS,Shivapurkar N,Mandal S,Stoner GD

    更新日期:1989-06-01 00:00:00

  • CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics.

    abstract::We recently identified the immunoglobulin-CAM CD155/PVR (the poliovirus receptor) as a regulator of cancer invasiveness and glioma migration, but the mechanism through which CD155/PVR controls these processes is unknown. Here, we show that expression of CD155/PVR in rat glioma cells that normally lack this protein enh...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1890

    authors: Sloan KE,Stewart JK,Treloar AF,Matthews RT,Jay DG

    更新日期:2005-12-01 00:00:00

  • Identification and characterization of the insulin receptor in the R3230AC mammary adenocarcinoma of the rat.

    abstract::The binding of labeled insulin to dissociated R3230AC mammary adenocarcinoma cells from diabetic and intact rats was investigated in vitro. At 20 degrees, specific binding (total binding minus binding in the presence of 1000-fold excess or 10(-6) M unlabeled insulin) reached a plateau at 45 to 60 min and was directly ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Harmon JT,Hilf R

    更新日期:1976-11-01 00:00:00

  • Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.

    abstract::A large number of poor prognosis neuroblastoma (NB) tumors constitutively express brain-derived neurotrophic factor (BDNF) and variably express the gene for its tyrosine kinase (Trk) receptor TrkB. Good prognosis NB tumors typically express high levels of TrkA mRNA, which encodes the signal transducing receptor for ne...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Matsumoto K,Wada RK,Yamashiro JM,Kaplan DR,Thiele CJ

    更新日期:1995-04-15 00:00:00

  • SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.

    abstract::SOX9 is a member of the SOX [Sry-related high-mobility group (HMG) box] family of HMG DNA-binding domain transcription factors and is required for the development and differentiation of multiple cell lineages. This report shows that basal epithelial cells express SOX9 in normal prostate, with no detectable expression ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1672

    authors: Wang H,McKnight NC,Zhang T,Lu ML,Balk SP,Yuan X

    更新日期:2007-01-15 00:00:00

  • Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.

    abstract::We report that p.o. administration of DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of polyamine biosynthesis, markedly inhibits the growth of established implants of cultured human small cell lung carcinoma (SCC) in athymic (nude) mice. Human SCC tumor cells, from a cell line which exhibited cell deat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Luk GD,Abeloff MD,Griffin CA,Baylin SB

    更新日期:1983-09-01 00:00:00

  • In situ hybridization analysis of interstitial C-heterochromatin in marker chromosomes of two human melanomas.

    abstract::Two distinct marker chromosomes, presenting with intercalated C- and distamycin A-Dapi-positive regions, were observed in a metastatic and a primary melanoma. To establish the origin of these heterochromatic sequences, we performed in situ hybridization analysis using specific probes for human repetitive DNA. The mark...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Doneda L,Ginelli E,Agresti A,Larizza L

    更新日期:1989-01-15 00:00:00

  • Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.

    abstract::The distribution and localization of a glioma-associated antigen defined by monoclonal antibody 81C6 has been examined using human cultured cell lines and tissues. Monoclonal antibody 81C6 was selected from a hybridoma fusion of spleen cells of mice immunized with the glial fibrillary acidic protein-positive human gli...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bourdon MA,Wikstrand CJ,Furthmayr H,Matthews TJ,Bigner DD

    更新日期:1983-06-01 00:00:00

  • ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth.

    abstract::Brain tumors such as medulloblastoma (MB) and glioblastoma multiforme (GBM) can derive from neural precursors. For instance, many MBs are thought to arise from the uncontrolled proliferation of cerebellar granule neuron precursors (GNP). GNPs normally proliferate in early postnatal stages in mice but then they become ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2249

    authors: Tatard VM,Xiang C,Biegel JA,Dahmane N

    更新日期:2010-02-01 00:00:00

  • Different effects of concanavalin A and E-phytohemagglutinin upon lymphocyte glycosyltransferase activities.

    abstract::We have studied glycosyltransferase activities in human lymphocytes stimulated with the plant mitogens E-phytohemagglutinin or concanavalin A (Con A) and have compared the results with activities found in resting lymphocytes. Compared to resting lymphocytes, Con A-stimulated lymphocytes possess an enhanced capacity to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Speckart SF,Boldt DH,Ryerson KL

    更新日期:1978-12-01 00:00:00

  • Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.

    abstract::Histone demethylase LSD1 (also known as KDM1 and AOF2) is active in various cancer cells, but its biological significance in human carcinogenesis is unexplored. In this study, we explored hypothesized interactions between LSD1 and MYPT1, a known regulator of RB1 phosphorylation. We found that MYPT1 was methylated in v...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2446

    authors: Cho HS,Suzuki T,Dohmae N,Hayami S,Unoki M,Yoshimatsu M,Toyokawa G,Takawa M,Chen T,Kurash JK,Field HI,Ponder BA,Nakamura Y,Hamamoto R

    更新日期:2011-02-01 00:00:00

  • IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.

    abstract::Statins are inhibitors of cholesterol biosynthesis and protein prenylation that also have been studied in cancer therapy and chemoprevention. With regard to natural killer (NK) cells, only inhibitory effects of statins such as suppression of granule exocytosis have been reported so far. In this study, we show that sta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1968

    authors: Gruenbacher G,Gander H,Nussbaumer O,Nussbaumer W,Rahm A,Thurnher M

    更新日期:2010-12-01 00:00:00

  • Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.

    abstract::Increased sialylation and branching of asparagine-linked oligosaccharides have recently been associated with both neoplastic transformation and the metastatic phenotype. Swainsonine, an inhibitor of Golgi alpha-mannosidase II blocks the synthesis of sialylated tri- and tetraantennary asparagine-linked oligosaccharides...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dennis JW

    更新日期:1986-10-01 00:00:00

  • Time dependence of the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity caused by alpha-difluoromethylornithine-induced polyamine depletion in 9L rat brain tumor cells.

    abstract::Treatment of 9L rat brain tumor cells with 1.0 mM alpha-difluoromethylornithine (DFMO) produced a time-dependent depletion of cellular putrescine and spermidine. An increase in the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) cytotoxicity, measured with a colony-forming efficiency assay, followed the ti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alhonen-Hongisto L,Deen DF,Marton LJ

    更新日期:1984-05-01 00:00:00

  • Increased synthesis of carbamoyl-phosphate synthase II (EC 6.3.5.5) in hepatoma 3924A.

    abstract::Carbamoyl-phosphate synthase II (glutamine-hydrolyzing) (EC 6.3.5.5) (synthase II) is the first and rate-limiting enzyme in the de novo UTP biosynthetic pathway. Leucine pulse-labeling in the rat demonstrated that in the rapidly proliferating hepatoma 3924A the ratio of radioactivity of synthase II to that of total cy...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reardon MA,Weber G

    更新日期:1986-07-01 00:00:00

  • Mouse models of human cancer consortium symposium on nervous system tumors.

    abstract::Nervous system tumors represent unique neoplasms that arise within the central and peripheral nervous system. Recent progress in generating genetically engineered mouse models of these tumors has advanced our understanding of the critical molecular and cellular events important for the development of these tumors. Rec...

    journal_title:Cancer research

    pub_type:

    doi:

    authors: Gutmann DH,Baker SJ,Giovannini M,Garbow J,Weiss W

    更新日期:2003-06-01 00:00:00

  • Mouse intestinal goblet cells expressing SV40 T antigen directed by the MUC2 mucin gene promoter undergo apoptosis upon migration to the villi.

    abstract::Mucinous colorectal cancers exhibit a characteristic set of molecular genetic alterations and may be derived from progenitor cells committed to the goblet cell lineage. Previously, we demonstrated that the MUC2 mucin gene promoter drives transgene reporter expression with high specificity in small intestinal goblet ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gum JR Jr,Hicks JW,Gillespie AM,Rius JL,Treseler PA,Kogan SC,Carlson EJ,Epstein CJ,Kim YS

    更新日期:2001-04-15 00:00:00

  • Potentiation of natural killer cell activity and tumor immunity by diacetylputrescine.

    abstract::The objective of the present investigation was to evaluate the immunomodulating properties of tetramethylenebisacetamide (N,N' 1-diacetylputrescine, DAP), a known inducer of cellular differentiation. We examined the effect of DAP administration in vivo on splenic and nonadherent peritoneal natural killer (NK) cell act...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bowlin TL,Rosenberger A,Stemerick D,Edwards ML

    更新日期:1990-09-01 00:00:00

  • Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells.

    abstract::The endoplasmic reticulum (ER) has been posited as a potential anticancer target. The synthetic antitumor alkyl-lysophospholipid analogue edelfosine accumulates in the ER of solid tumor cells. This ER accumulation of the drug leads to the inhibition of phosphatidylcholine and protein synthesis, G(2)-M arrest, depletio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0278

    authors: Nieto-Miguel T,Fonteriz RI,Vay L,Gajate C,López-Hernández S,Mollinedo F

    更新日期:2007-11-01 00:00:00

  • Tumor-promoting phorbol diester-induced specific changes in cell surface glycoprotein profile of K562 human leukemic cells.

    abstract::The tumor-promoting phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), induced specific changes in the cell surface glycoprotein profile of K562 human leukemic cells. TPA-treated K562 cells were examined by cell surface labeling followed by immunoprecipitation with anti-glycophorin antiserum or anti-K562 antis...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fukuda M

    更新日期:1981-11-01 00:00:00

  • Widespread loss of gelsolin in breast cancers of humans, mice, and rats.

    abstract::Down-regulation of gelsolin, an actin-binding protein, is frequently found in several types of transformed cells and tumors. The present study demonstrates that gelsolin protein and RNA were absent or markedly reduced in human breast cancer cell lines relative to "normal" mortal human mammary epithelial cells and beni...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Asch HL,Head K,Dong Y,Natoli F,Winston JS,Connolly JL,Asch BB

    更新日期:1996-11-01 00:00:00

  • Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.

    abstract::Piroxantrone is an anthrapyrazole derivative with broad antitumor activity in vitro. In previous phase I trials, the dose-limiting toxicity of this agent was myelosuppression. Therefore, a phase I and pharmacokinetic study of a 1-h infusion of piroxantrone in combination with granulocyte-colony stimulating factor was ...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Berg SL,Savarese DM,Balis FM,Denicoff AM,Hillig M,O'Shaughnessy JA,Poplack DG,Cowan KH

    更新日期:1993-06-01 00:00:00